Sainte
Sainte builds a trauma-informed care platform that unifies reentry support for managed care plans.
Founded
2023Sainte builds a trauma-informed care platform that unifies reentry support for managed care plans.
Sainte competes less with named care-management vendors than with the fragmented manual coordination that states, correctional facilities and community providers run today. The federal reentry demonstrations it targets fund pre-release case management and peer supports, and fragmented care coordination between correctional and community providers remained the central problem for these demonstrations as of July 2026.
Direct rivalry here turns on distribution into state and health-plan contracts, where Acentra Health is the competitor that sells to both states and managed care organizations. Carceral Care serves incarcerated people and those reentering their communities with physical, behavioral and social care, while Sainte pairs a predictive platform with navigator-mediated supports aimed at trauma-impacted and justice-involved members.
Source: acentra.com
The reentry waiver market Sainte addresses peaked in approvals before 2026 and then closed to new state programs, which favors incumbents already selling to states and managed care plans. CMS had approved 19 Reentry Section 1115 Demonstrations by April 2025 with nine states pending, funding pre-release case management and peer supports, and on April 10, 2025 it said it did not anticipate approving new state proposals of 1115 expenditure authority. Acentra Health sells Carceral Care to states and managed care organizations under those waivers.
The risks that could invalidate the Sainte thesis are financing scale and a single buyer motion that has not produced a documented contract. The company has raised more than USD 300,000 from Techstars and the Michigan Founders Fund, and in the second quarter of 2025 it solicited limited pilot spots with a Medicaid managed care organization.
Policy dependence compounds those risks, because the reentry funding stream Sainte sells against was restricted in 2025 and faces a new federal test in 2027. CMS said on April 10, 2025 that it did not anticipate approving new state proposals of Section 1115 expenditure authority, and statutory budget-neutrality certification for the demonstrations begins January 1, 2027. The warning signs to watch are a signed health-plan contract and a second sales channel, neither of which Sainte has announced as of October 2026.
The demand that remains sits in implementation rather than in new approvals, and it falls on plans and providers rather than on new state entrants. By July 20, 2026, states were preparing correctional facilities, managed care organizations and providers for these demonstrations, and fragmented care coordination between correctional and community providers remained the problem to solve. Statutory budget-neutrality certification for 1115 demonstrations begins January 1, 2027, putting approved programs under recurring federal cost review.
Source: healthmanagement.com
Source: medicaid.gov